SEDAJECT DIN 02492431
Health Canada record
| Active ingredient(s) | DEXMEDETOMIDINE HYDROCHLORIDE 0.5 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular; Intravenous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 22-Jan-2021 |
| Current status date | 22-Jan-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Grey Wolf Animal Health Inc. — licence 3-002474, currently licensed, last inspection rating C (2022-11-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DEXMEDETOMIDINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02333929 | DEXDOMITOR | ORION CORPORATION | Solution | DEXMEDETOMIDINE HYDROCHLORIDE 0.5 MG | Marketed |
| 02524945 | DEXMEDESED | DECHRA VETERINARY PRODUCTS INC. | Solution | DEXMEDETOMIDINE HYDROCHLORIDE 0.5 MG | Marketed |
| 02483947 | DEXVETIDINE | MODERN VETERINARY THERAPEUTICS LLC | Solution | DEXMEDETOMIDINE HYDROCHLORIDE 0.5 MG | Marketed |
| 02530392 | SILEO | ORION CORPORATION | Gel | DEXMEDETOMIDINE HYDROCHLORIDE 0.1 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22706 | 2019-09-26 | Abbreviated New Drug Submission (ANDS) |
International API supply for DEXMEDETOMIDINE HYDROCHLORIDE
16 active FDA Drug Master Files.
Request a quote for SEDAJECT